Articles from Profluent Bio

Profluent Bio announced a research collaboration with the Rett Syndrome Research Trust (RSRT) to design novel base editors to permanently correct inherited mutations that lead to Rett syndrome, a rare neurodevelopmental disorder. The partnership centers on families living with Rett every day and is grounded in a shared commitment to move the therapeutic science forward with urgency, rigor, and transparency.

Profluent Bio, a pioneer in generative AI for protein design, announced today a strategic collaboration with Corteva, a global leader in agricultural sciences and solutions. Under the collaboration, the companies will use artificial intelligence (AI) and gene editing to deliver a new generation of more sustainable, resilient crops.